{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-038220","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2026-05-26T21:20:29+00:00","discovered_at":"2026-05-26T21:22:00.190159+00:00","generated_at":"2026-05-26T21:22:48.202218+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"confidence":"high","headline":"Precision BioSciences shareholders approve 3.8M share increase for equity plan; elect directors","bullets":["Shareholders approved amendment to 2019 Incentive Award Plan, increasing share reserve by 3.8M shares (58% for, 42% against).","Amendment to certificate of incorporation approved (17.9M for, 1.4M against) to allow officer exculpation under Delaware law.","Melinda Brown and Geno Germano elected as Class I directors (14.3M and 14.3M votes for respectively).","Ratified Deloitte & Touche as independent auditor for FY2026 (22.2M for, 99k against).","Advisory say-on-pay approved (18.7M for, 613k against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-038220","json":"https://secwatch.observer/filing/0001628280-26-038220.json","markdown":"https://secwatch.observer/filing/0001628280-26-038220.md","text":"https://secwatch.observer/filing/0001628280-26-038220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/0001628280-26-038220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000162828026038220/dtil-20260521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T21:22:48.202218+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}